Zoetis (ZTS) Interest Coverage Ratio Growth (1y) (2013 - 2026)
Zoetis (ZTS) Interest Coverage Ratio Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.30 Bn | 39.65 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.45 Bn | 29.77 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | -83.16% |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 128.45% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -97.39% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.70 Bn | 11.17 Bn | 798.00 Mn | -8.29% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Alkermes | 8.11 Bn | 7.46 Bn | 397.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -17.20% |
| Mar 31, 2026 | -14.04% |
| Dec 31, 2025 | -3,617.36% |
| Sep 30, 2025 | -0.28% |
| Jun 30, 2025 | 22.84% |
| Mar 31, 2025 | 27.44% |
| Dec 31, 2024 | -24.40% |
| Sep 30, 2024 | 19.92% |
| Jun 30, 2024 | 2.41% |
| Mar 31, 2024 | 46.71% |
| Dec 31, 2023 | -10.21% |
| Sep 30, 2023 | -2.31% |
| Jun 30, 2023 | 3.49% |
| Mar 31, 2023 | -10.14% |
| Dec 31, 2022 | 253.00% |
| Sep 30, 2022 | 4.96% |
| Jun 30, 2022 | 10.15% |
| Mar 31, 2022 | 71.81% |
| Dec 31, 2021 | -64.92% |
| Sep 30, 2021 | 30.28% |